Sei Investments Co. Purchases 21,970 Shares of The Clorox Company (NYSE:CLX)

Sei Investments Co. increased its position in shares of The Clorox Company (NYSE:CLX - Free Report) by 28.6% during the 4th quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 98,794 shares of the company's stock after purchasing an additional 21,970 shares during the period. Sei Investments Co. owned 0.08% of Clorox worth $16,045,000 at the end of the most recent quarter.

A number of other institutional investors have also recently added to or reduced their stakes in CLX. Integral Investment Advisors Inc. boosted its stake in Clorox by 4.1% during the fourth quarter. Integral Investment Advisors Inc. now owns 1,718 shares of the company's stock valued at $279,000 after buying an additional 67 shares in the last quarter. HCR Wealth Advisors lifted its holdings in Clorox by 1.0% in the 4th quarter. HCR Wealth Advisors now owns 6,870 shares of the company's stock valued at $1,116,000 after acquiring an additional 68 shares during the last quarter. Sound View Wealth Advisors Group LLC boosted its position in shares of Clorox by 6.1% during the 4th quarter. Sound View Wealth Advisors Group LLC now owns 1,345 shares of the company's stock valued at $218,000 after purchasing an additional 77 shares in the last quarter. Brooklyn Investment Group grew its stake in shares of Clorox by 163.8% in the 4th quarter. Brooklyn Investment Group now owns 153 shares of the company's stock worth $25,000 after purchasing an additional 95 shares during the last quarter. Finally, Global X Japan Co. Ltd. raised its holdings in shares of Clorox by 3.0% in the 4th quarter. Global X Japan Co. Ltd. now owns 3,272 shares of the company's stock worth $531,000 after purchasing an additional 95 shares in the last quarter. 78.53% of the stock is currently owned by institutional investors and hedge funds.

Remove Ads

Clorox Stock Up 0.7 %

CLX stock traded up $1.00 during trading hours on Monday, hitting $147.28. The company's stock had a trading volume of 1,201,840 shares, compared to its average volume of 1,278,756. The company has a market capitalization of $18.14 billion, a PE ratio of 40.24, a price-to-earnings-growth ratio of 2.62 and a beta of 0.45. The stock has a 50 day moving average price of $151.34 and a two-hundred day moving average price of $159.00. The company has a quick ratio of 0.60, a current ratio of 0.94 and a debt-to-equity ratio of 20.52. The Clorox Company has a 12 month low of $127.60 and a 12 month high of $171.37.

Clorox (NYSE:CLX - Get Free Report) last posted its earnings results on Monday, February 3rd. The company reported $1.55 EPS for the quarter, topping the consensus estimate of $1.39 by $0.16. Clorox had a net margin of 6.38% and a return on equity of 316.87%. During the same quarter in the prior year, the business earned $2.16 EPS. On average, equities research analysts expect that The Clorox Company will post 7.15 earnings per share for the current year.

Clorox Announces Dividend

The business also recently announced a quarterly dividend, which will be paid on Friday, May 9th. Shareholders of record on Wednesday, April 23rd will be given a dividend of $1.22 per share. The ex-dividend date is Wednesday, April 23rd. This represents a $4.88 dividend on an annualized basis and a yield of 3.31%. Clorox's payout ratio is currently 133.33%.

Analyst Ratings Changes

A number of brokerages recently weighed in on CLX. Evercore ISI raised their target price on shares of Clorox from $145.00 to $155.00 in a report on Tuesday, February 4th. Royal Bank of Canada reissued a "sector perform" rating and set a $150.00 price objective on shares of Clorox in a research note on Thursday, January 30th. StockNews.com downgraded Clorox from a "buy" rating to a "hold" rating in a report on Sunday, January 5th. Wells Fargo & Company upped their price target on shares of Clorox from $157.00 to $161.00 and gave the company an "equal weight" rating in a research report on Tuesday, February 4th. Finally, DA Davidson cut their target price on shares of Clorox from $171.00 to $169.00 and set a "neutral" rating on the stock in a research note on Wednesday, February 5th. Three research analysts have rated the stock with a sell rating, ten have assigned a hold rating and one has given a buy rating to the company's stock. According to MarketBeat.com, the company presently has a consensus rating of "Hold" and an average target price of $159.50.

Clorox Company Profile

The Clorox Company manufactures and markets consumer and professional products worldwide. It operates through four segments: Health and Wellness, Household, Lifestyle, and International. The Health and Wellness segment offers cleaning products, such as laundry additives and home care products primarily under the Clorox, Clorox2, Scentiva, Pine-Sol, Liquid-Plumr, Tilex, and Formula 409 brands; professional cleaning and disinfecting products under the CloroxPro and Clorox Healthcare brands; professional food service products under the Hidden Valley brand; and vitamins, minerals and supplement products under the RenewLife, Natural Vitality, NeoCell, and Rainbow Light brands in the United States.